Invention Grant
- Patent Title: Nicotinamide riboside and pterostilbene compositions and methods for treatment of skin disorders
-
Application No.: US17872575Application Date: 2022-07-25
-
Publication No.: US12109206B2Publication Date: 2024-10-08
- Inventor: Eric A. Marcotulli , Daniel A. Alminana , Paul M. Bowen
- Applicant: Elysium Health, Inc.
- Applicant Address: US NY New York
- Assignee: Elysium Health, Inc.
- Current Assignee: Elysium Health, Inc.
- Current Assignee Address: US NY New York
- Agency: Foley Hoag LLP
- Agent Brendan T. Jones; Allison L. Gilder
- Main IPC: A61K8/368
- IPC: A61K8/368 ; A61K8/67 ; A61K9/00 ; A61K9/48 ; A61K31/09 ; A61K31/455 ; A61K31/706 ; A61P17/00 ; A61Q19/00
Abstract:
Compositions containing a combination of nicotinamide riboside and pterostilbene for treating skin disorders, and methods of treating skin disorders using these compositions and their equivalents are described. The skin disorders that are treated using these compositions or methods include sun exposure-related skin disorders, inflammatory skin disorders, autoimmune disease-related skin disorders and cancer-related skin disorders. In one embodiment, the compositions containing a combination of nicotinamide riboside and pterostilbene are prepared as oral formulations.
Public/Granted literature
- US20220362233A1 NICOTINAMIDE RIBOSIDE AND PTEROSTILBENE COMPOSITIONS AND METHODS FOR TREATMENT OF SKIN DISORDERS Public/Granted day:2022-11-17
Information query
